Call for Abstract
4th International Conference & Exhibition on Metabolic Syndrome, will be organized around the theme “Promoting Care, Prevention and Cure Worldwide”
Metabolic Syndrome 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Metabolic Syndrome 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases and its specific secretions known as hormones, growth promotion and malignancy. Behavioural endocrinology is the study of hormonal processes and neuroendocrine systems that influence or regulate behaviour. Endocrinology includes the wide area that not only affects our endocrine system but also has effects on the skin which shows indirectly involvement of dermatology.
Metabolic syndrome is a medical disorder result in the formation of a cluster of conditions that includes, increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels that occur together, increasing your risk of heart disease, stroke and diabetes. Metabolic syndrome is closely linked to overweight or obesity and inactivity and also linked to a condition called insulin resistance. Genetic factors influence each individual component of the syndrome, and the syndrome itself. Metabolic syndrome is also known as syndrome X, insulin resistance syndrome, or dysmetabolic syndrome.
- Track 1-1Signs and symptoms
- Track 1-2Causes of Endocrine Disorders and Metabolic Syndromes
- Track 1-3Pathophysiology of Endocrinology and Metabolic Syndrome
- Track 1-4Diagnosis and Preventions of Endocrinology and Metabolic Syndrome
- Track 1-5Epidemiology and Management of Endocrinology and Metabolic Syndrome
- Track 1-6Diagnosis, Treatments and Medications
- Track 1-7Risk factors associated with Endocrinology and Metabolic Syndrome
Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction. Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.
The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%.
- Track 2-1Types of Cardiovascular disease
- Track 2-2Risk factors associated with CVD
- Track 2-3Pathophysiology of Cardiovascular disease
- Track 2-4Screening of Cardiovascular disease
- Track 2-5Prevention and Management of Cardiovascular disease
- Track 2-6Research and Methodology of CVDs
Endocrine disorders involve the body’s over- or under-production of certain hormones, while metabolic disorders affect the body’s ability to process certain nutrients and vitamins. Endocrine disorders include hypothyroidism, congenital adrenal hyperplasia, diseases of the parathyroid gland, diabetes mellitus, diseases of the adrenal glands (including Cushing’s syndrome and Addison’s disease), and ovarian dysfunction (including polycystic ovary syndrome), among others. Some examples of metabolic disorders include cystic fibrosis, phenylketonuria (PKU), hyperlipidemia, gout, and rickets.
- Track 3-1Anatomy and Physiology
- Track 3-2Thyroid underactivity/overactivity
- Track 3-3Causes and Symptoms
- Track 3-4Types and Treatments
- Track 3-5Diagnosis and Screening
- Track 3-6Development and Function
- Track 3-7Clinical significance and Management
Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.
Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM.
- Track 4-1Diabetic Neuropathy
- Track 4-2Causes of Diabetes
- Track 4-3Pathophysiology of Diabetes
- Track 4-4Diagnosis and Prognosis for DM
- Track 4-5Prevention and Management
- Track 4-6Major Clinical Trials and Research
Obesity is a medical condition in which excess body fat has accumulated to the extent that it may have a negative effect on health. People are generally considered obese when their body mass index (BMI), a measurement obtained by dividing a person's weight by the square of the person's height, is over 30 kg/m2, with the range 25–30 kg/m2 defined as overweight. Obesity increases the likelihood of various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, osteoarthritis and depression.
Diabetes is one of the most challenging health problems in the 21st century and one of the most common non-communicable diseases globally. It is the 4th or 5th leading cause of death in most high-income countries, with ~366 million diabetics in 2011 and an estimated 552 million in 2030. On the other hand, obesity has also become a worldwide epidemic. Obesity is a risk factor for the development of insulin resistance, with pancreatic beta cells compensating for insulin resistance by augmenting insulin secretion. The failure of beta-cells is believed to cause pre-diabetes, a condition that can lead to diabetes. Approximately 85% of people with diabetes are type 2, and of these, 90% are obese or overweight. Diabetes & obesity are major contributors to various other chronic diseases such as coronary artery diseases, myocardial infarction, hypertension, dyslipidemia and a number of other complicated disorders mounting evidence shows that a Mediterranean style-diet may be useful in preventing and treating chronic diseases related to mild chronic inflammation such as visceral (abdominal) obesity, metabolic syndrome, and Type 2 diabetes.
- Track 5-1Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Track 5-2Classification and Correlation
- Track 5-3Relations and functions
- Track 5-4Alteration and Variation in Obesity, Diabetes and Metabolism
- Track 5-5Causes and Complications
- Track 5-6Epidemiology and Management
Bariatric surgery (weight loss surgery) includes a variety of procedures performed on people who have obesity. Weight loss is achieved by reducing the size of the stomach with a gastric band or through removal of a portion of the stomach (sleeve gastrectomy or biliopancreatic diversion with duodenal switch) or by resecting and re-routing the small intestine to a small stomach pouch (gastric bypass surgery).
Long-term studies show the procedures cause significant long-term loss of weight, recovery from diabetes, improvement in cardiovascular risk factors, and a mortality reduction from 40% to 23%. Bariatric surgery for obese people with a body mass index (BMI) of at least 40, and for people with BMI of at least 35 and serious coexisting medical conditions such as diabetes. However, research is emerging that suggests bariatric surgery could be appropriate for those with a BMI of 35 to 40 with no comorbidities or a BMI of 30 to 35 with significant comorbidities. Metabolic & Bariatric Surgery guidelines suggest the position statement on consensus for BMI as an indication for bariatric surgery. Bariatric surgical procedures cause weight loss by restricting the amount of food the stomach can hold, causing malabsorption of nutrients, or by a combination of both gastric restriction and malabsorption. Bariatric procedures also often cause hormonal changes.
- Track 6-1Gastric bypass (Roux-en-Y), Endoscopic sleeve gastroplasty and Intragastric balloon
- Track 6-2Advantages and Disadvantages
- Track 6-3Psychiatric/Psychological changes
- Track 6-4Reduced mortality and morbidity
- Track 6-5Procedure and Treatment
- Track 6-6Costs and Benefits of Bariatric surgery
- Track 6-7Outcomes and Complications
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species and a biological system's ability to readily detoxify the reactive intermediates or to repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. Oxidative stress from oxidative metabolism causes base damage, as well as strand breaks in DNA. Base damage is mostly indirect and caused by reactive oxygen species (ROS) generated, e.g. O2− (superoxide radical), OH (hydroxyl radical) and H2O2 (hydrogen peroxide). Further, some reactive oxidative species act as cellular messengers in redox signalling. Thus, oxidative stress can cause disruptions in normal mechanisms of cellular signalling.
Insulin resistance (IR) is a pathological condition in which cells fail to respond normally to the hormone insulin. To prevent hyperglycemia and noticeable organ damage over time, the body produces insulin when glucose starts to be released into the bloodstream from the digestion of carbohydrates (primarily) in the diet. Under normal conditions of insulin reactivity, this insulin response triggers glucose being taken into body cells, to be used for energy, and inhibits the body from using fat for energy, thereby causing the concentration of glucose in the blood to decrease as a result, staying within the normal range even when a large amount of carbohydrates is consumed. A habitually high intake of carbohydrates, simple sugars, and particularly fructose, e.g. with sweetened beverages, contributes to insulin resistance and has been linked to weight gain and obesity. If high and excess blood sugar from the digestion of primarily carbohydrates in the diet is not sufficiently absorbed by cells even in the presence of insulin, the increase in the level of blood sugar can result in the classic hyperglycemic triad of polyphagia (increased appetite), polydipsia (increased thirst), and polyuria (increased urination). Avoiding carbohydrates and sugars, a no-carbohydrate diet or fasting can reverse insulin resistance
- Track 7-1Signs and symptoms
- Track 7-2Glucose tolerance testing
- Track 7-3Causes and Associated risk factors
- Track 7-4Chemical and biological effects
- Track 7-5Antioxidants as supplements
- Track 7-6Pathophysiology and Diagnosis
- Track 7-7Male infertility and Aging
Metabolic responses and Nutrition focuses on the integration of nutrition, exercise physiology, clinical investigations, and molecular and cellular biochemistry of metabolism. The areas of interest of Nutrition & Metabolism encompass studies in obesity, diabetes, lipidemias, metabolic syndrome and exercise physiology that have an underlying basis in metabolism. In persons with type 2 diabetes, protein ingestion results in little or no increase in plasma glucose concentrations but a stimulation of insulin and glucagon secretion. The nutritional requirements of a neonate are significantly greater than those of an adult because not only are there requirements for substrate intake to fulfill basic metabolic needs, but there are metabolic needs to maintain rapid and continued growth and development.
- Track 8-1Metabolic response and nutritional support in traumatic brain injury
- Track 8-2Nutrition and Metabolic response in Health and Disease
- Track 8-3Metabolic response to Hypoxia
- Track 8-4Response to ingested glycine
- Track 8-5Metabolic Response Modifiers
- Track 8-6Response to Acute Spinal-Cord Injury
- Track 8-7Nutritional and Metabolic Stress
Clustering of various metabolic parameters including abdominal obesity, hyperglycaemia, low high-density lipoprotein cholesterol, elevated triglycerides and hypertension have been used worldwide as metabolic syndrome to predict cardiometabolic risk. Thyroid dysfunction impacts on various levels of these components. Hormones are used to communicate between organs and tissues for physiological regulation and behavioral activities, such as digestion, metabolism, respiration, tissue function, sensory perception, sleep, excretion, lactation, stress, growth and development, movement, reproduction, and mood. Hormones affect distant cells by binding to specific receptor proteins in the target cell resulting in a change in cell function. When a hormone binds to the receptor, it results in the activation of a signal transduction pathway that typically activates gene transcription resulting in increased expression of target proteins; non-genomic effects are more rapid, and can be synergistic with genomic effects. Hormone secretion may occur in many tissues. Endocrine glands are the cardinal example, but specialized cells in various other organs also secrete hormones. Hormone secretion occurs in response to specific biochemical signals from a wide range of regulatory systems.
- Track 9-1Introduction and its Overview
- Track 9-2Hormonal Signalling and Binding proteins
- Track 9-3Receptors and their Regulation
- Track 9-4Metabolism and its Effects
- Track 9-5Hormone-behaviour interactions
- Track 9-6Therapeutic use and approaches
- Track 9-7Discovery
Metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that include hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is strongly associated with an increased risk for developing diabetes and atherosclerotic and nonatherosclerotic cardiovascular disease (CVD). The pathogenesis of MetS involves both genetic and acquired factors that contribute to the final pathway of inflammation that leads to CVD. MetS has gained significant importance recently due to the exponential increase in obesity worldwide. Early diagnosis is important in order to employ lifestyle and risk factor modification. Here, we review the epidemiology and pathogenesis of MetS, the role of inflammation in MetS, and summarize existing natural therapies for MetS.
- Track 10-1Pathways and Mechanisms
- Track 10-2Linkage and heredity associations
- Track 10-3Insulin resistance and Glucose intolerance
- Track 10-4Obesity and increased waist circumference
- Track 10-5Dyslipidaemia and Hypertension
- Track 10-6Etiology of endocrine disorders
- Track 10-7Complications of diabetes mellitus
- Track 10-8Associated autoimmune conditions
Reproductive endocrinologist is a very important part of obstetrics and gynaecology in which physician is trained in reproductive medicine explaining about hormonal functioning as it indirectly relate to reproduction. They are trained to evaluate and treat malfunctioning in females and males outside infertility. Reproductive endocrinologists have special training in obstetrics and gynecology before they undergo sub-specialty training in Reproductive endocrinology and infertility.
Reproductive endocrinology and infertility is a surgical subspecialty of obstetrics and gynaecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to reproduction as well as the issue of infertility. While most reproductive endocrinology and infertility specialists primarily focus on the treatment of infertility, reproductive endocrinologists are trained to also evaluate and treat hormonal dysfunctions in females and males outside infertility.
- Track 11-1Hypothalamic pituitary dysfunction
- Track 11-2Dysfunction of Male & Female Reproductive Organ
- Track 11-3Other disorders of the female & male reproductive tract
- Track 11-4Polycystic ovarian syndrome (PCOS)
- Track 11-5Miscellaneous Endocrine conditions
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder, where the main clinical features include menstrual irregularities, sub-fertility, hyperandrogenism, and hirsutism. The prevalence of PCOS depends on ethnicity, environmental and genetic factors, as well as the criteria used to define it. On the other hand, metabolic syndrome is a constellation of metabolic disorders which include mainly abdominal obesity, insulin resistance, impaired glucose metabolism, hypertension and dyslipidaemia. These associated disorders directly increase the risk of Type 2 diabetes mellitus (DMT2), coronary heart disease (CHD), cardiovascular diseases (CVD) and endometrial cancer. Many patients with PCOS have features of metabolic syndrome such as visceral obesity, hyperinsulinaemia and insulin resistance. These place patients with PCOS under high risk of developing cardiovascular disease (CVD), Type 2 diabetes (DMT2) and gynecological cancer, in particular, endometrial cancer. Metabolic syndrome is also increased in infertile women with PCOS. The aim of this review is to provide clear and up to date information about PCOS and its relationship with metabolic syndrome, and the possible interaction between different metabolic disorders.
- Track 12-1Signs and Symptoms
- Track 12-2Causes and its Complications
- Track 12-3Relation with Metabolic syndrome
- Track 12-4Pathogenesis of PCOS
- Track 12-5Diagnosis and Management
- Track 12-6Prognosis of PCOS
Clinical study aims directly improve global health outcomes and share clinical knowledge using case reports to convey important best practice messages. If case study is done then the advanced medical technologies like Transplantation, holistic treatment can be used more rapidly in hospitals and with the more study in Glycemic index and load we can find the diseases or problem like Cortisol . Clinical case study done in medical diabetes could leads to find innovative way for treating the diabetes. Endocrine surgeons and Endocrinologists typically work closely together to provide the most advantageous care to patients afflicted with endocrine disorders.
- Track 13-1Clinical Trails and Case Study
- Track 13-2Research and Development
- Track 13-3Nursing Care: Roles and Practices
- Track 13-4Assessments and Evaluation
- Track 13-5Advantages and its outcomes
Metabolic syndrome (MetS) consists of several medical conditions that collectively predict the risk for cardiovascular disease better than the sum of individual conditions. The risk of developing MetS in human depends on synergy of both genetic and environmental factors. Being a multifactorial condition with alarming rate of prevalence nowadays, establishment of appropriate experimental animal models mimicking the disease state in humans is crucial in order to solve the difficulties in evaluating the pathophysiology of MetS in human. Metabolic syndrome has been defined as a group of risk factors that directly contribute to the development of cardiovascular disease and/or type 2 diabetes. Insulin resistance seems to have a fundamental role in the genesis of this syndrome. Over the past years to the present day, basic and translational research has used small animal models to explore the pathophysiology of metabolic syndrome and to develop novel therapies that might slow the progression of this prevalent condition.
- Track 14-1Diet-induced models of Metabolic Syndrome
- Track 14-2Tools and Tests
- Track 14-3Cardiovascular Changes in Animal Models of Metabolic Syndrome
- Track 14-4Characterization and its Application
- Track 14-5Challenges and Complications
- Track 14-6Genetic models of MetS
- Track 14-7Drug/chemically-induced model of MetS
- Track 14-8Other animal models of MetS
Energy metabolism is the process of generating energy (ATP) from nutrients. Metabolism comprises a series of interconnected pathways that can function in the presence or absence of oxygen. Aerobic metabolism converts one glucose molecule into 30-32 ATP molecules. The syndrome is thought to be caused by an underlying disorder of energy utilization and storage.
The best way to manage your stress is to learn healthy coping strategies. You can start practicing these tips right away. Try one or two until you find a few that work for you. Practice these techniques until they become habits you turn to when you feel stress. You can also use this coping strategies form to see how you respond to stress. Stress-relief techniques focus on relaxing your mind and your body.
- Track 15-1Energy metabolism and Transduction
- Track 15-2Glucose Metabolism and Energy Production
- Track 15-3Stress prevention and resilience
- Track 15-4Stress Management programs
- Track 15-5Health realization/innate health model
- Track 15-6Yoga and Medication
- Track 15-7Tools and Techniques
Endocrinology and Metabolic disorders are inherited genetic defects that interfere with the body’s metabolism, or the process by which the body gets energy from food. Symptoms vary from syndrome to syndrome, but often include developmental delays, vision and hearing problems, loss of intellectual function, muscle weakness, seizures, abnormal movements, stunted growth, pain and shortened life span. A successful bone marrow or stem cell transplant may help slow or halt the progression of certain syndromes, but early diagnosis is critical to prevent irreversible disease progression.
- Track 16-1Sources and storage of cells
- Track 16-2Treatments: Advantages and Disadvantages
- Track 16-3Stem Cell Transplant for Metabolic Disorders
- Track 16-4Stem Cell Transplantation in Inherited Metabolic Disorders
- Track 16-5Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
- Track 16-6Complications and Prognosis
- Track 16-7Research and its Applications
R&D Systems offers a range of quality products to study the enzymatic cascades that govern these metabolic reactions. Novel remedial targets accessible for diabetes incorporates Incretion based treatments, oral helpful operators like secretagogues, beta cell recovery and expansion and foundational microorganism treatments. Embryonic undeveloped cell and fetal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes. Aside from the above, different computational methodologies in Diabetes administration control have been presented as of late which are assuming an imperative part in recognizable proof of qualities bringing about diabetes helping in Early Detection of Diabetes. These procedures are likewise valuable in concentrating on the compound etiologist of Diabetes revealing different treatment prospects and model development forms for survival expectation.
The World Health Organization require the presence of any one of diabetes mellitus, impaired glucose tolerance, impaired fasting glucose or insulin resistance. The European Group for the Study of Insulin Resistance requires insulin resistance defined as the top 25% of the fasting insulin values among non-diabetic individuals.
- Track 17-1Regulation and Standards for Metabolic Disorders
- Track 17-2Measurement and Control for MetS
- Track 17-3Statutory authority and Management Planning
- Track 17-4Resource and Outcomes
- Track 17-5Policies and strategies in the planning process
- Track 17-6Training and Practices
Various Diabetes and Endocrinology Center was established to improve the quality of life for people with diabetes and other endocrinology disorders. For diabetes patients, complications and sufferings contribute to the ultimate prevention and cure. For patients with other endocrinology disorders, including nodules in the endocrine system. New technologies have been developed to prevent everyone from the Metabolic Syndromes.
- Track 18-1Informatics in the Service of Medicine, Telemedicine, Software and other Technologies
- Track 18-2New Technologies for Treating Obesity and Preventing Related Diabetes
- Track 18-3Adolescent Weight Loss (Bariatric) Surgery
- Track 18-4Glucometer, Thyroid Sonography, Computed Tomography
- Track 19-1Advancement in Metabolic Measurements
- Track 19-2Latest Product and Instrument
- Track 19-3Development, Validation, and Pilot Testing of Metabolic Syndrome
- Track 19-4Dietary Patterns in Relation to Metabolic Syndrome
- Track 19-5Screening for metabolic syndrome in addiction care
- Track 19-6Metabolic Immunoassays
- Track 19-7Metabolic Syndrome: Arrays and Biochips
Muscle cell needs a lot of energy, which means they burn a lot of calories. In fact, they burn more calories than fat cells, even when you're not exercising. So the time you spend working out reaps benefits long after you stop sweating. Exercise becomes even more important as you get older. You naturally lose muscle mass with age, which slows down your metabolism. Working out can stop that slide.
Healthy eating is one of the best things you can do to prevent and control health problems such as heart disease, high blood pressure, type 2 diabetes, and some types of cancer. Weight management is a long-term approach to a healthy lifestyle. It includes a balance of healthy eating and physical exercise to equate energy expenditure and energy intake. Developing healthy eating habits while using tips that will keep us fuller longer can be useful tools in weight management. Knowing what your body needs is important to weight management and can control over consumption and under consumption of food. Weight management does not include fad diets that promote quick, temporary weight loss. It focuses on the long-term results that are achieved through slow weight loss, followed by retention of an ideal body weight for age, sex and height.
Herbal and alternative remedies have been utilized for health and restorative purposes for a few a great many years, majority of people still using herbal medicine to meet their wellbeing needs. Herbal supplements for the treatment of Hormonal Problems such as Estrogen and Progesterone in Women and Treatment for menopausal Hormone Imbalance, etc. Homeopathy is a technique for treating disease by medications, given in moment dosages that would deliver in sound individual indications like those of the illness.
- Track 22-1Anti-obesity herbal medicine
- Track 22-2Adaptogen Herbs
- Track 22-3Ayurvedic Medicine
- Track 22-4Herbs and supplements